Market Analysis and Insights: Global Drug Discovery Assays Market
The global Drug Discovery Assays market is projected to grow from US$ 7779.2 million in 2024 to US$ 12900 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.8% during the forecast period.
The Drug Discovery Assays market is a fundamental and dynamic sector within the pharmaceutical and biotechnology industry, offering a wide array of techniques and tools to identify and validate potential drug candidates. These assays encompass various approaches, such as high-throughput screening, cell-based assays, biochemical assays, and target-based assays, which are vital in the drug discovery process, from target identification to lead optimization. They are known for their ability to provide critical insights into the pharmacological and toxicological properties of compounds, facilitating the development of novel drugs and therapies.
The market is characterized by ongoing technological advancements, automation, and the integration of artificial intelligence and machine learning to enhance the efficiency and accuracy of drug discovery processes. Leading providers in the life sciences and biotechnology sector, including PerkinElmer, Thermo Fisher Scientific, and Promega Corporation, focus on delivering innovative assay technologies and platforms that cater to the evolving needs of pharmaceutical companies and research institutions.
As the pharmaceutical industry continues to advance toward personalized medicine, precision therapeutics, and the development of treatments for various diseases, the Drug Discovery Assays market is poised for sustained growth, offering indispensable tools for accelerating drug discovery, improving drug safety, and enhancing the efficiency of bringing new medications to market.
Report Covers:
This report presents an overview of global market for Drug Discovery Assays market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drug Discovery Assays, also provides the revenue of main regions and countries. of the upcoming market potential for Drug Discovery Assays, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug Discovery Assays revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Drug Discovery Assays market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Drug Discovery Assays revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
Global Drug Discovery Assays Companies Covered
Thermo Fisher Scientific, Danaher, Becton Dickinson, GE Healthcare, Merck, Lonza, PerkinElmer, Inc., Charles River Laboratories, Inc., Cell Signaling Technologies, Cisbio, Cell Biolabs, Inc., Promega, Pfizer, GSK, Agilent, Eli Lilly and Company, Roche, Bayer, Abbott, AstraZeneca, Shimadzu
Global Drug Discovery Assays Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Discovery Assays Market, Segment by Type
Consumables
Instruments
Services
Software
Global Drug Discovery Assays Market, Segment by Application
Pharmaceutical and Biotechnology Companies
Academic and Government Institutions
Contract Research Organizations
Others
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Drug Discovery Assays in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Discovery Assays companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Discovery Assays revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Discovery Assays Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Consumables
1.2.3 Instruments
1.2.4 Services
1.2.5 Software
1.3 Market by Application
1.3.1 Global Drug Discovery Assays Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic and Government Institutions
1.3.4 Contract Research Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Discovery Assays Market Perspective (2019-2030)
2.2 Global Drug Discovery Assays Growth Trends by Region
2.2.1 Drug Discovery Assays Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Discovery Assays Historic Market Size by Region (2019-2024)
2.2.3 Drug Discovery Assays Forecasted Market Size by Region (2025-2030)
2.3 Drug Discovery Assays Market Dynamics
2.3.1 Drug Discovery Assays Industry Trends
2.3.2 Drug Discovery Assays Market Drivers
2.3.3 Drug Discovery Assays Market Challenges
2.3.4 Drug Discovery Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Drug Discovery Assays by Players
3.1.1 Global Drug Discovery Assays Revenue by Players (2019-2024)
3.1.2 Global Drug Discovery Assays Revenue Market Share by Players (2019-2024)
3.2 Global Drug Discovery Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drug Discovery Assays, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Drug Discovery Assays Market Concentration Ratio
3.4.1 Global Drug Discovery Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery Assays Revenue in 2023
3.5 Global Key Players of Drug Discovery Assays Head office and Area Served
3.6 Global Key Players of Drug Discovery Assays, Product and Application
3.7 Global Key Players of Drug Discovery Assays, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Discovery Assays Breakdown Data by Type
4.1 Global Drug Discovery Assays Historic Market Size by Type (2019-2024)
4.2 Global Drug Discovery Assays Forecasted Market Size by Type (2025-2030)
5 Drug Discovery Assays Breakdown Data by Application
5.1 Global Drug Discovery Assays Historic Market Size by Application (2019-2024)
5.2 Global Drug Discovery Assays Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Discovery Assays Market Size (2019-2030)
6.2 North America Drug Discovery Assays Market Size by Type
6.2.1 North America Drug Discovery Assays Market Size by Type (2019-2024)
6.2.2 North America Drug Discovery Assays Market Size by Type (2025-2030)
6.2.3 North America Drug Discovery Assays Market Share by Type (2019-2030)
6.3 North America Drug Discovery Assays Market Size by Application
6.3.1 North America Drug Discovery Assays Market Size by Application (2019-2024)
6.3.2 North America Drug Discovery Assays Market Size by Application (2025-2030)
6.3.3 North America Drug Discovery Assays Market Share by Application (2019-2030)
6.4 North America Drug Discovery Assays Market Size by Country
6.4.1 North America Drug Discovery Assays Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Drug Discovery Assays Market Size by Country (2019-2024)
6.4.3 North America Drug Discovery Assays Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Drug Discovery Assays Market Size (2019-2030)
7.2 Europe Drug Discovery Assays Market Size by Type
7.2.1 Europe Drug Discovery Assays Market Size by Type (2019-2024)
7.2.2 Europe Drug Discovery Assays Market Size by Type (2025-2030)
7.2.3 Europe Drug Discovery Assays Market Share by Type (2019-2030)
7.3 Europe Drug Discovery Assays Market Size by Application
7.3.1 Europe Drug Discovery Assays Market Size by Application (2019-2024)
7.3.2 Europe Drug Discovery Assays Market Size by Application (2025-2030)
7.3.3 Europe Drug Discovery Assays Market Share by Application (2019-2030)
7.4 Europe Drug Discovery Assays Market Size by Country
7.4.1 Europe Drug Discovery Assays Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Drug Discovery Assays Market Size by Country (2019-2024)
7.4.3 Europe Drug Discovery Assays Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Drug Discovery Assays Market Size (2019-2030)
8.2 China Drug Discovery Assays Market Size by Type
8.2.1 China Drug Discovery Assays Market Size by Type (2019-2024)
8.2.2 China Drug Discovery Assays Market Size by Type (2025-2030)
8.2.3 China Drug Discovery Assays Market Share by Type (2019-2030)
8.3 China Drug Discovery Assays Market Size by Application
8.3.1 China Drug Discovery Assays Market Size by Application (2019-2024)
8.3.2 China Drug Discovery Assays Market Size by Application (2025-2030)
8.3.3 China Drug Discovery Assays Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Drug Discovery Assays Market Size (2019-2030)
9.2 Asia Drug Discovery Assays Market Size by Type
9.2.1 Asia Drug Discovery Assays Market Size by Type (2019-2024)
9.2.2 Asia Drug Discovery Assays Market Size by Type (2025-2030)
9.2.3 Asia Drug Discovery Assays Market Share by Type (2019-2030)
9.3 Asia Drug Discovery Assays Market Size by Application
9.3.1 Asia Drug Discovery Assays Market Size by Application (2019-2024)
9.3.2 Asia Drug Discovery Assays Market Size by Application (2025-2030)
9.3.3 Asia Drug Discovery Assays Market Share by Application (2019-2030)
9.4 Asia Drug Discovery Assays Market Size by Region
9.4.1 Asia Drug Discovery Assays Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Drug Discovery Assays Market Size by Region (2019-2024)
9.4.3 Asia Drug Discovery Assays Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Drug Discovery Assays Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Drug Discovery Assays Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drug Discovery Assays Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Drug Discovery Assays Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Drug Discovery Assays Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Drug Discovery Assays Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drug Discovery Assays Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Drug Discovery Assays Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Drug Discovery Assays Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Drug Discovery Assays Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drug Discovery Assays Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Drug Discovery Assays Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Drug Discovery Assays Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Drug Discovery Assays Introduction
11.1.4 Thermo Fisher Scientific Revenue in Drug Discovery Assays Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Danaher
11.2.1 Danaher Company Details
11.2.2 Danaher Business Overview
11.2.3 Danaher Drug Discovery Assays Introduction
11.2.4 Danaher Revenue in Drug Discovery Assays Business (2019-2024)
11.2.5 Danaher Recent Developments
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Details
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Drug Discovery Assays Introduction
11.3.4 Becton Dickinson Revenue in Drug Discovery Assays Business (2019-2024)
11.3.5 Becton Dickinson Recent Developments
11.4 GE Healthcare
11.4.1 GE Healthcare Company Details
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Drug Discovery Assays Introduction
11.4.4 GE Healthcare Revenue in Drug Discovery Assays Business (2019-2024)
11.4.5 GE Healthcare Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Drug Discovery Assays Introduction
11.5.4 Merck Revenue in Drug Discovery Assays Business (2019-2024)
11.5.5 Merck Recent Developments
11.6 Lonza
11.6.1 Lonza Company Details
11.6.2 Lonza Business Overview
11.6.3 Lonza Drug Discovery Assays Introduction
11.6.4 Lonza Revenue in Drug Discovery Assays Business (2019-2024)
11.6.5 Lonza Recent Developments
11.7 PerkinElmer, Inc.
11.7.1 PerkinElmer, Inc. Company Details
11.7.2 PerkinElmer, Inc. Business Overview
11.7.3 PerkinElmer, Inc. Drug Discovery Assays Introduction
11.7.4 PerkinElmer, Inc. Revenue in Drug Discovery Assays Business (2019-2024)
11.7.5 PerkinElmer, Inc. Recent Developments
11.8 Charles River Laboratories, Inc.
11.8.1 Charles River Laboratories, Inc. Company Details
11.8.2 Charles River Laboratories, Inc. Business Overview
11.8.3 Charles River Laboratories, Inc. Drug Discovery Assays Introduction
11.8.4 Charles River Laboratories, Inc. Revenue in Drug Discovery Assays Business (2019-2024)
11.8.5 Charles River Laboratories, Inc. Recent Developments
11.9 Cell Signaling Technologies
11.9.1 Cell Signaling Technologies Company Details
11.9.2 Cell Signaling Technologies Business Overview
11.9.3 Cell Signaling Technologies Drug Discovery Assays Introduction
11.9.4 Cell Signaling Technologies Revenue in Drug Discovery Assays Business (2019-2024)
11.9.5 Cell Signaling Technologies Recent Developments
11.10 Cisbio
11.10.1 Cisbio Company Details
11.10.2 Cisbio Business Overview
11.10.3 Cisbio Drug Discovery Assays Introduction
11.10.4 Cisbio Revenue in Drug Discovery Assays Business (2019-2024)
11.10.5 Cisbio Recent Developments
11.11 Cell Biolabs, Inc.
11.11.1 Cell Biolabs, Inc. Company Details
11.11.2 Cell Biolabs, Inc. Business Overview
11.11.3 Cell Biolabs, Inc. Drug Discovery Assays Introduction
11.11.4 Cell Biolabs, Inc. Revenue in Drug Discovery Assays Business (2019-2024)
11.11.5 Cell Biolabs, Inc. Recent Developments
11.12 Promega
11.12.1 Promega Company Details
11.12.2 Promega Business Overview
11.12.3 Promega Drug Discovery Assays Introduction
11.12.4 Promega Revenue in Drug Discovery Assays Business (2019-2024)
11.12.5 Promega Recent Developments
11.13 Pfizer
11.13.1 Pfizer Company Details
11.13.2 Pfizer Business Overview
11.13.3 Pfizer Drug Discovery Assays Introduction
11.13.4 Pfizer Revenue in Drug Discovery Assays Business (2019-2024)
11.13.5 Pfizer Recent Developments
11.14 GSK
11.14.1 GSK Company Details
11.14.2 GSK Business Overview
11.14.3 GSK Drug Discovery Assays Introduction
11.14.4 GSK Revenue in Drug Discovery Assays Business (2019-2024)
11.14.5 GSK Recent Developments
11.15 Agilent
11.15.1 Agilent Company Details
11.15.2 Agilent Business Overview
11.15.3 Agilent Drug Discovery Assays Introduction
11.15.4 Agilent Revenue in Drug Discovery Assays Business (2019-2024)
11.15.5 Agilent Recent Developments
11.16 Eli Lilly and Company
11.16.1 Eli Lilly and Company Company Details
11.16.2 Eli Lilly and Company Business Overview
11.16.3 Eli Lilly and Company Drug Discovery Assays Introduction
11.16.4 Eli Lilly and Company Revenue in Drug Discovery Assays Business (2019-2024)
11.16.5 Eli Lilly and Company Recent Developments
11.17 Roche
11.17.1 Roche Company Details
11.17.2 Roche Business Overview
11.17.3 Roche Drug Discovery Assays Introduction
11.17.4 Roche Revenue in Drug Discovery Assays Business (2019-2024)
11.17.5 Roche Recent Developments
11.18 Bayer
11.18.1 Bayer Company Details
11.18.2 Bayer Business Overview
11.18.3 Bayer Drug Discovery Assays Introduction
11.18.4 Bayer Revenue in Drug Discovery Assays Business (2019-2024)
11.18.5 Bayer Recent Developments
11.19 Abbott
11.19.1 Abbott Company Details
11.19.2 Abbott Business Overview
11.19.3 Abbott Drug Discovery Assays Introduction
11.19.4 Abbott Revenue in Drug Discovery Assays Business (2019-2024)
11.19.5 Abbott Recent Developments
11.20 AstraZeneca
11.20.1 AstraZeneca Company Details
11.20.2 AstraZeneca Business Overview
11.20.3 AstraZeneca Drug Discovery Assays Introduction
11.20.4 AstraZeneca Revenue in Drug Discovery Assays Business (2019-2024)
11.20.5 AstraZeneca Recent Developments
11.21 Shimadzu
11.21.1 Shimadzu Company Details
11.21.2 Shimadzu Business Overview
11.21.3 Shimadzu Drug Discovery Assays Introduction
11.21.4 Shimadzu Revenue in Drug Discovery Assays Business (2019-2024)
11.21.5 Shimadzu Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Drug Discovery Assays Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Consumables
Table 3. Key Players of Instruments
Table 4. Key Players of Services
Table 5. Key Players of Software
Table 6. Global Drug Discovery Assays Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Global Drug Discovery Assays Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Drug Discovery Assays Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Drug Discovery Assays Market Share by Region (2019-2024)
Table 10. Global Drug Discovery Assays Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Drug Discovery Assays Market Share by Region (2025-2030)
Table 12. Drug Discovery Assays Market Trends
Table 13. Drug Discovery Assays Market Drivers
Table 14. Drug Discovery Assays Market Challenges
Table 15. Drug Discovery Assays Market Restraints
Table 16. Global Drug Discovery Assays Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Drug Discovery Assays Revenue Share by Players (2019-2024)
Table 18. Global Top Drug Discovery Assays by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery Assays as of 2023)
Table 19. Global Drug Discovery Assays Industry Ranking 2022 VS 2023 VS 2024
Table 20. Global 5 Largest Players Market Share by Drug Discovery Assays Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Drug Discovery Assays, Headquarters and Area Served
Table 22. Global Key Players of Drug Discovery Assays, Product and Application
Table 23. Global Key Players of Drug Discovery Assays, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drug Discovery Assays Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Drug Discovery Assays Revenue Market Share by Type (2019-2024)
Table 27. Global Drug Discovery Assays Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Drug Discovery Assays Revenue Market Share by Type (2025-2030)
Table 29. Global Drug Discovery Assays Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Drug Discovery Assays Revenue Share by Application (2019-2024)
Table 31. Global Drug Discovery Assays Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Drug Discovery Assays Revenue Share by Application (2025-2030)
Table 33. North America Drug Discovery Assays Market Size by Type (2019-2024) & (US$ Million)
Table 34. North America Drug Discovery Assays Market Size by Type (2025-2030) & (US$ Million)
Table 35. North America Drug Discovery Assays Market Size by Application (2019-2024) & (US$ Million)
Table 36. North America Drug Discovery Assays Market Size by Application (2025-2030) & (US$ Million)
Table 37. North America Drug Discovery Assays Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Drug Discovery Assays Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Drug Discovery Assays Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Drug Discovery Assays Market Size by Type (2019-2024) & (US$ Million)
Table 41. Europe Drug Discovery Assays Market Size by Type (2025-2030) & (US$ Million)
Table 42. Europe Drug Discovery Assays Market Size by Application (2019-2024) & (US$ Million)
Table 43. Europe Drug Discovery Assays Market Size by Application (2025-2030) & (US$ Million)
Table 44. Europe Drug Discovery Assays Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Europe Drug Discovery Assays Market Size by Country (2019-2024) & (US$ Million)
Table 46. Europe Drug Discovery Assays Market Size by Country (2025-2030) & (US$ Million)
Table 47. China Drug Discovery Assays Market Size by Type (2019-2024) & (US$ Million)
Table 48. China Drug Discovery Assays Market Size by Type (2025-2030) & (US$ Million)
Table 49. China Drug Discovery Assays Market Size by Application (2019-2024) & (US$ Million)
Table 50. China Drug Discovery Assays Market Size by Application (2025-2030) & (US$ Million)
Table 51. Asia Drug Discovery Assays Market Size by Type (2019-2024) & (US$ Million)
Table 52. Asia Drug Discovery Assays Market Size by Type (2025-2030) & (US$ Million)
Table 53. Asia Drug Discovery Assays Market Size by Application (2019-2024) & (US$ Million)
Table 54. Asia Drug Discovery Assays Market Size by Application (2025-2030) & (US$ Million)
Table 55. Asia Drug Discovery Assays Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 56. Asia Drug Discovery Assays Market Size by Region (2019-2024) & (US$ Million)
Table 57. Asia Drug Discovery Assays Market Size by Region (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Drug Discovery Assays Market Size by Type (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drug Discovery Assays Market Size by Type (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drug Discovery Assays Market Size by Application (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Drug Discovery Assays Market Size by Application (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Drug Discovery Assays Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 63. Middle East, Africa, and Latin America Drug Discovery Assays Market Size by Country (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Drug Discovery Assays Market Size by Country (2025-2030) & (US$ Million)
Table 65. Thermo Fisher Scientific Company Details
Table 66. Thermo Fisher Scientific Business Overview
Table 67. Thermo Fisher Scientific Drug Discovery Assays Product
Table 68. Thermo Fisher Scientific Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 69. Thermo Fisher Scientific Recent Developments
Table 70. Danaher Company Details
Table 71. Danaher Business Overview
Table 72. Danaher Drug Discovery Assays Product
Table 73. Danaher Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 74. Danaher Recent Developments
Table 75. Becton Dickinson Company Details
Table 76. Becton Dickinson Business Overview
Table 77. Becton Dickinson Drug Discovery Assays Product
Table 78. Becton Dickinson Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 79. Becton Dickinson Recent Developments
Table 80. GE Healthcare Company Details
Table 81. GE Healthcare Business Overview
Table 82. GE Healthcare Drug Discovery Assays Product
Table 83. GE Healthcare Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 84. GE Healthcare Recent Developments
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Drug Discovery Assays Product
Table 88. Merck Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 89. Merck Recent Developments
Table 90. Lonza Company Details
Table 91. Lonza Business Overview
Table 92. Lonza Drug Discovery Assays Product
Table 93. Lonza Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 94. Lonza Recent Developments
Table 95. PerkinElmer, Inc. Company Details
Table 96. PerkinElmer, Inc. Business Overview
Table 97. PerkinElmer, Inc. Drug Discovery Assays Product
Table 98. PerkinElmer, Inc. Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 99. PerkinElmer, Inc. Recent Developments
Table 100. Charles River Laboratories, Inc. Company Details
Table 101. Charles River Laboratories, Inc. Business Overview
Table 102. Charles River Laboratories, Inc. Drug Discovery Assays Product
Table 103. Charles River Laboratories, Inc. Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 104. Charles River Laboratories, Inc. Recent Developments
Table 105. Cell Signaling Technologies Company Details
Table 106. Cell Signaling Technologies Business Overview
Table 107. Cell Signaling Technologies Drug Discovery Assays Product
Table 108. Cell Signaling Technologies Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 109. Cell Signaling Technologies Recent Developments
Table 110. Cisbio Company Details
Table 111. Cisbio Business Overview
Table 112. Cisbio Drug Discovery Assays Product
Table 113. Cisbio Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 114. Cisbio Recent Developments
Table 115. Cell Biolabs, Inc. Company Details
Table 116. Cell Biolabs, Inc. Business Overview
Table 117. Cell Biolabs, Inc. Drug Discovery Assays Product
Table 118. Cell Biolabs, Inc. Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 119. Cell Biolabs, Inc. Recent Developments
Table 120. Promega Company Details
Table 121. Promega Business Overview
Table 122. Promega Drug Discovery Assays Product
Table 123. Promega Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 124. Promega Recent Developments
Table 125. Pfizer Company Details
Table 126. Pfizer Business Overview
Table 127. Pfizer Drug Discovery Assays Product
Table 128. Pfizer Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 129. Pfizer Recent Developments
Table 130. GSK Company Details
Table 131. GSK Business Overview
Table 132. GSK Drug Discovery Assays Product
Table 133. GSK Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 134. GSK Recent Developments
Table 135. Agilent Company Details
Table 136. Agilent Business Overview
Table 137. Agilent Drug Discovery Assays Product
Table 138. Agilent Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 139. Agilent Recent Developments
Table 140. Eli Lilly and Company Company Details
Table 141. Eli Lilly and Company Business Overview
Table 142. Eli Lilly and Company Drug Discovery Assays Product
Table 143. Eli Lilly and Company Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 144. Eli Lilly and Company Recent Developments
Table 145. Roche Company Details
Table 146. Roche Business Overview
Table 147. Roche Drug Discovery Assays Product
Table 148. Roche Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 149. Roche Recent Developments
Table 150. Bayer Company Details
Table 151. Bayer Business Overview
Table 152. Bayer Drug Discovery Assays Product
Table 153. Bayer Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 154. Bayer Recent Developments
Table 155. Abbott Company Details
Table 156. Abbott Business Overview
Table 157. Abbott Drug Discovery Assays Product
Table 158. Abbott Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 159. Abbott Recent Developments
Table 160. AstraZeneca Company Details
Table 161. AstraZeneca Business Overview
Table 162. AstraZeneca Drug Discovery Assays Product
Table 163. AstraZeneca Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 164. AstraZeneca Recent Developments
Table 165. Shimadzu Company Details
Table 166. Shimadzu Business Overview
Table 167. Shimadzu Drug Discovery Assays Product
Table 168. Shimadzu Revenue in Drug Discovery Assays Business (2019-2024) & (US$ Million)
Table 169. Shimadzu Recent Developments
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Discovery Assays Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Drug Discovery Assays Market Share by Type: 2023 VS 2030
Figure 3. Consumables Features
Figure 4. Instruments Features
Figure 5. Services Features
Figure 6. Software Features
Figure 7. Global Drug Discovery Assays Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Drug Discovery Assays Market Share by Application: 2023 VS 2030
Figure 9. Pharmaceutical and Biotechnology Companies Case Studies
Figure 10. Academic and Government Institutions Case Studies
Figure 11. Contract Research Organizations Case Studies
Figure 12. Others Case Studies
Figure 13. Drug Discovery Assays Report Years Considered
Figure 14. Global Drug Discovery Assays Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Drug Discovery Assays Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Drug Discovery Assays Market Share by Region: 2023 VS 2030
Figure 17. Global Drug Discovery Assays Market Share by Players in 2023
Figure 18. Global Top Drug Discovery Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery Assays as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Drug Discovery Assays Revenue in 2023
Figure 20. North America Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Drug Discovery Assays Market Share by Type (2019-2030)
Figure 22. North America Drug Discovery Assays Market Share by Application (2019-2030)
Figure 23. North America Drug Discovery Assays Market Share by Country (2019-2030)
Figure 24. United States Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Drug Discovery Assays Market Size YoY (2019-2030) & (US$ Million)
Figure 27. Europe Drug Discovery Assays Market Share by Type (2019-2030)
Figure 28. Europe Drug Discovery Assays Market Share by Application (2019-2030)
Figure 29. Europe Drug Discovery Assays Market Share by Country (2019-2030)
Figure 30. Germany Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. China Drug Discovery Assays Market Size YoY (2019-2030) & (US$ Million)
Figure 37. China Drug Discovery Assays Market Share by Type (2019-2030)
Figure 38. China Drug Discovery Assays Market Share by Application (2019-2030)
Figure 39. Asia Drug Discovery Assays Market Size YoY (2019-2030) & (US$ Million)
Figure 40. Asia Drug Discovery Assays Market Share by Type (2019-2030)
Figure 41. Asia Drug Discovery Assays Market Share by Application (2019-2030)
Figure 42. Asia Drug Discovery Assays Market Share by Region (2019-2030)
Figure 43. Japan Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. South Korea Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Taiwan Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. India Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Australia Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Drug Discovery Assays Market Size YoY (2019-2030) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Drug Discovery Assays Market Share by Type (2019-2030)
Figure 51. Middle East, Africa, and Latin America Drug Discovery Assays Market Share by Application (2019-2030)
Figure 52. Middle East, Africa, and Latin America Drug Discovery Assays Market Share by Country (2019-2030)
Figure 53. Brazil Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Mexico Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Turkey Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Israel Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. GCC Countries Drug Discovery Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 60. Danaher Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 61. Becton Dickinson Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 62. GE Healthcare Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 63. Merck Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 64. Lonza Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 65. PerkinElmer, Inc. Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 66. Charles River Laboratories, Inc. Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 67. Cell Signaling Technologies Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 68. Cisbio Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 69. Cell Biolabs, Inc. Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 70. Promega Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 71. Pfizer Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 72. GSK Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 73. Agilent Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 74. Eli Lilly and Company Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 75. Roche Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 76. Bayer Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 77. Abbott Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 78. AstraZeneca Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 79. Shimadzu Revenue Growth Rate in Drug Discovery Assays Business (2019-2024)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.